News & Events about Abbvie Inc.
Fool.com Headlines
1month ago
Vertex dominates the cystic fibrosis market today.Vertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The company is known for its combination therapies targeting a defective protein that causes the disease's devastating symptoms.But one possible threat to ...
Fool.com Headlines
1month ago
You'll want to hold on to these top stocks for the long term.If you have $20,000 to invest, you could put it all in one stock -- or you could invest across several. I favor buying a few stocks that can each offer you something different. For instance, one may pay you a top-notch dividend, another ...
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant...
Allergan Aesthetics Celebrates the Journeys of Women Surgeons with LIMITLESS Allergan Aesthetics Celebrates the Journeys of Women Surgeons with LIMITLESS PR Newswire IRVINE, Calif., April 18, 2023 Women surgeons breaking the boundaries of leadership presented in partnership with the American...
AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease PR Newswire NORTH...